Methotrexate Versus Secukinumab Safety in Psoriasis Patients With Metabolic Syndrome
Clinical trial NCT04469829 · UNKNOWN
Trial details
- NCT number
- NCT04469829
- Sponsor
- Universita di Verona
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-01
- Primary completion
- 2021-12-31
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.